About Pippa Study
Welcome to the Pippa app:
Pippa app is a proprietary platform of ObvioHealth being to understand participants’ experiences with their breast cancer treatment through online surveys, which will be available within the study app
Download Pippa Study App
A subject who is identified as eligible for this study will be asked to participate via email.
Informed Consent
Subjects create a Pippa study account and complete the Informed Consent process. A series of screens explains the parameters of the study, including:
o Privacy Policy
o Data Gathering & Usage
o Study Tasks & Surveys
o Time Commitment
o Option to Withdraw
Subjects will have the opportunity to connect with a member of the study team to ask questions prior to signing the informed consent form.
Assessment Period:
Complete Questionnaires
o Subjects will contribute data to the study by completing questionnaires
Pippa Study details
Pippa Study is a free Medical app for Android with 5+ installs on Google Play and a 5.0/5 average rating from 1 rating. It was released on January 27, 2022 and last updated on May 23, 2022. It's developed by ObvioHealth. It requires Android 6.0 or later.
- Category
- Medical
- Rating
- 5.0 / 5 (1 rating)
- Installs
- 5+
- Price
- Free
- In-app purchases
- No
- Ads
- No ads
- Current version
- 1.0.2
- Requires Android
- 6.0
- Content rating
- Everyone
- Released
- January 27, 2022
- Last updated
- May 23, 2022
- Developer
- ObvioHealth
What’s new in Pippa Study
General enhancements and other bug fixes
Version 1.0.2 · Updated May 23, 2022
Similar Apps
Jovie Study
Welcome to the Jovie Study: The Jovie app is a proprietary platform of...
ObvioGo
Welcome to ObvioGo:ObvioGo is a proprietary platform of ObvioHealth being used to...
Bobbie Study
Welcome to the Bobbie Study: The Bobbie app is a proprietary platform of...
Noro202 Study
Norovirus is a very contagious virus (infection) sometimes referred to as a...
Otrivine Study
Welcome to the Otrivine Study: The Otrivine app is a proprietary platform of...
NOVASTIM
Welcome to the NOVASTIM study: Non-invasive Stimulation Therapy for Overactive Bladder: A...